Australia markets closed

REGENXBIO Inc. (RGNX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
14.45+0.10 (+0.70%)
As of 09:34AM EDT. Market open.
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
34,522
96,952
345,209
338,426
-
Other short-term investments
240,736
267,690
112,230
137,314
-
Total cash
275,258
364,642
457,439
475,740
-
Net receivables
265
280
365
30,573
-
Other current assets
18,852
7,142
10,196
1,953
-
Total current assets
334,971
415,976
518,826
531,197
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
249,798
248,189
221,487
142,956
-
Accumulated depreciation
-57,208
-41,388
-29,036
-22,674
-
Net property, plant and equipment
192,590
206,801
192,451
120,282
-
Equity and other investments
38,871
200,560
391,907
46,809
-
Other long-term assets
6,837
8,427
8,458
6,609
-
Total non-current assets
238,999
417,292
595,078
176,967
-
Total assets
573,970
833,268
1,113,904
708,164
-
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
22,786
27,213
11,387
10,622
-
Taxes payable
-
0
11,325
3,135
0
Accrued liabilities
31,557
28,723
44,937
32,792
-
Deferred revenues
148
1,829
3,333
449
-
Other current liabilities
50,567
48,601
37,889
18,794
-
Total current liabilities
130,272
130,434
130,472
81,447
-
Non-current liabilities
Deferred revenues
-
-
0
3,783
3,333
Other long-term liabilities
49,734
97,837
134,205
175,028
-
Total non-current liabilities
131,956
186,639
219,134
248,964
-
Total liabilities
262,228
317,073
349,606
330,411
-
Stockholders' equity
Common stock
4
4
4
4
-
Retained earnings
-705,047
-441,553
-161,232
-289,072
-
Accumulated other comprehensive income
-4,429
-15,401
-2,569
-360
-
Total stockholders' equity
311,742
516,195
764,298
377,753
-
Total liabilities and stockholders' equity
573,970
833,268
1,113,904
708,164
-